These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 19469648)

  • 21. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of BRCA1 and BRCA2 mutations in women diagnosed with ductal carcinoma in situ.
    Claus EB; Petruzella S; Matloff E; Carter D
    JAMA; 2005 Feb; 293(8):964-9. PubMed ID: 15728167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Breast cancer prognosis in BRCA1 and BRCA2 mutation carriers: an International Prospective Breast Cancer Family Registry population-based cohort study.
    Goodwin PJ; Phillips KA; West DW; Ennis M; Hopper JL; John EM; O'Malley FP; Milne RL; Andrulis IL; Friedlander ML; Southey MC; Apicella C; Giles GG; Longacre TA
    J Clin Oncol; 2012 Jan; 30(1):19-26. PubMed ID: 22147742
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of breast cancer in women who carry BRCA1 or BRCA2 mutations: a critical review of the literature.
    Calderon-Margalit R; Paltiel O
    Int J Cancer; 2004 Nov; 112(3):357-64. PubMed ID: 15382059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical outcomes of breast cancer in carriers of BRCA1 and BRCA2 mutations.
    Rennert G; Bisland-Naggan S; Barnett-Griness O; Bar-Joseph N; Zhang S; Rennert HS; Narod SA
    N Engl J Med; 2007 Jul; 357(2):115-23. PubMed ID: 17625123
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging.
    Plevritis SK; Kurian AW; Sigal BM; Daniel BL; Ikeda DM; Stockdale FE; Garber AM
    JAMA; 2006 May; 295(20):2374-84. PubMed ID: 16720823
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening for BRCA1 and BRCA2 mutations among French-Canadian breast cancer cases attending an outpatient clinic in Montreal.
    Ghadirian P; Robidoux A; Nassif E; Martin G; Potvin C; Patocskai E; Younan R; Larouche N; Venne A; Zhang S; Royer R; Narod SA
    Clin Genet; 2014 Jan; 85(1):31-5. PubMed ID: 23621881
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Breast cancer following ovarian cancer in BRCA mutation carriers.
    Gangi A; Cass I; Paik D; Barmparas G; Karlan B; Dang C; Li A; Walsh C; Rimel BJ; Amersi FF
    JAMA Surg; 2014 Dec; 149(12):1306-13. PubMed ID: 25372568
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.
    Casey MJ; Synder C; Bewtra C; Narod SA; Watson P; Lynch HT
    Gynecol Oncol; 2005 May; 97(2):457-67. PubMed ID: 15863145
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation of climatic factors and dengue incidence in Metro Manila, Philippines.
    Su GL
    Ambio; 2008 Jun; 37(4):292-4. PubMed ID: 18686509
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of several BRCA1 and BRCA2 mutations in a hospital-based series of unselected breast cancer cases.
    Burcoş T; Cimponeriu D; Ion DA; Spandole S; Apostol P; Toma M; Radu I; Popa I; Stanilescu S; Popa E
    Chirurgia (Bucur); 2013; 108(4):468-72. PubMed ID: 23958087
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preliminary monocentric results of biological characteristics of pregnancy associated breast cancer.
    Michieletto S; Saibene T; Evangelista L; Barbazza F; Grigoletto R; Rossi G; Ghiotto C; Bozza F
    Breast; 2014 Feb; 23(1):19-25. PubMed ID: 24189101
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term prospective clinical follow-up after BRCA1/2 presymptomatic testing: BRCA2 risks higher than in adjusted retrospective studies.
    Evans DG; Harkness E; Lalloo F; Howell A
    J Med Genet; 2014 Sep; 51(9):573-80. PubMed ID: 25053764
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence and risk factors for HIV infection among men having sex with men in Metro Manila, Philippines.
    Gangcuangco LM; Tan ML; Berba RP
    Southeast Asian J Trop Med Public Health; 2013 Sep; 44(5):810-7. PubMed ID: 24437316
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk of breast cancer recurrence and contralateral breast cancer in relation to BRCA1 and BRCA2 mutation status following breast-conserving surgery and radiotherapy.
    Kirova YM; Stoppa-Lyonnet D; Savignoni A; Sigal-Zafrani B; Fabre N; Fourquet A;
    Eur J Cancer; 2005 Oct; 41(15):2304-11. PubMed ID: 16140006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Geographic and ethnic differences in childhood leukaemia and lymphoma survival: comparisons of Philippine residents, Asian Americans and Caucasians in the United States.
    Redaniel MT; Laudico A; Mirasol-Lumague MR; Alcasabas AP; Pulte D; Brenner H
    Br J Cancer; 2010 Jun; 103(1):149-54. PubMed ID: 20485290
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term follow-up of Jewish women with a BRCA1 and BRCA2 mutation who underwent population genetic screening.
    Metcalfe KA; Mian N; Enmore M; Poll A; Llacuachaqui M; Nanda S; Sun P; Hughes KS; Narod SA
    Breast Cancer Res Treat; 2012 Jun; 133(2):735-40. PubMed ID: 22240989
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Population-based study of changing breast cancer risk in Icelandic BRCA2 mutation carriers, 1920-2000.
    Tryggvadottir L; Sigvaldason H; Olafsdottir GH; Jonasson JG; Jonsson T; Tulinius H; Eyfjörd JE
    J Natl Cancer Inst; 2006 Jan; 98(2):116-22. PubMed ID: 16418514
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The spectrum of BRCA1 and BRCA2 mutations in breast cancer patients in the Bahamas.
    Akbari MR; Donenberg T; Lunn J; Curling D; Turnquest T; Krill-Jackson E; Zhang S; Narod SA; Hurley J
    Clin Genet; 2014 Jan; 85(1):64-7. PubMed ID: 23458327
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence of and treatment for ductal carcinoma in situ of the breast.
    Ernster VL; Barclay J; Kerlikowske K; Grady D; Henderson C
    JAMA; 1996 Mar; 275(12):913-8. PubMed ID: 8598618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.